Bottom line
What does CFRCX hold?
CFRCX held 370 positions as of Jun 30, 2026. Its largest holding is First American Funds Inc at 5.46% of the fund, and the top 10 positions add up to 16.8%. By asset type it is 4% stocks, 6% bonds, 84% loans.
Updated Aug 28, 2026
CFRCX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | First American Funds Inc FIRST AM-TR OB-X |
Cash & short-term funds | 5.46% | $42.2M |
| 2 | Invesco Exchange-traded Fund Trust II INVESCO SENIOR L |
Stocks | 2.37% | $18.4M |
| 3 | Ssga Active Trust SPDR BLACKSTONE |
Stocks | 1.95% | $15.1M |
| 4 | Broadstreet Partners Inc BROPAR TL B 1L USD |
Loans | 1.13% | $8.7M |
| 5 | LifePoint Health RGCARE TL B 1L USD |
Loans | 1.08% | $8.3M |
| 6 | Ukg ULTI TL B 1L USD |
Loans | 0.98% | $7.6M |
| 7 | Allied Universal UNSEAM TL B 1L USD |
Loans | 0.98% | $7.6M |
| 8 | N/a BLCOCN TL B 1L USD |
Loans | 0.97% | $7.5M |
| 9 | Syneos Health fka INC Research/inVentiv Health SYNH TL B 1L USD |
Loans | 0.96% | $7.4M |
| 10 | Cengage Learning CNGO TL B 1L USD |
Loans | 0.90% | $6.9M |
| 11 | Heartland Dental HEARTL TL B 1L USD |
Loans | 0.85% | $6.6M |
| 12 | Garda World Security GWCN TL B 1L USD |
Loans | 0.84% | $6.5M |
| 13 | Team Health TMH TL B 1L USD |
Loans | 0.82% | $6.3M |
| 14 | Warner Bros. Discovery WBD TL B 1L USD |
Loans | 0.81% | $6.3M |
| 15 | BMC Software BMC TL B 1L USD |
Loans | 0.81% | $6.3M |
| 16 | Cotiviti Inc VCVHHO TL B 1L USD |
Loans | 0.80% | $6.2M |
| 17 | Sophos Group SOPHLN TL B 1L USD |
Loans | 0.73% | $5.7M |
| 18 | athenahealth ATHENA TL B 1L USD |
Loans | 0.73% | $5.7M |
| 19 | Truist Insurance Holdings TIHLLC TL B 1L USD |
Loans | 0.73% | $5.6M |
| 20 | Opella (Sanofi consumer healthcare) OPALBD TL B 1L USD |
Loans | 0.72% | $5.6M |
| 21 | WestJet Airlines WJACN TL B 1L USD |
Loans | 0.72% | $5.6M |
| 22 | Golden State Foods GLDNST TL B 1L USD |
Loans | 0.71% | $5.5M |
| 23 | Zelis Healthcare STRATO TL B 1L USD |
Loans | 0.71% | $5.5M |
| 24 | Presidio PSDO TL B 1L USD |
Loans | 0.71% | $5.5M |
| 25 | Genmab A/s RCAP TL B3 1L USD |
Loans | 0.70% | $5.4M |
Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 28, 2026